Clover Health stock has an average target price of $9.50, which represents an upside potential of over 6.6 percent. Currently, the sentiments are negative towards CLOV stock, which might impact the price action in the short term.
However, the stock could go up in the long term considering the massive market opportunity. According to Clover Health, Medicare Advantage spending in the U.S. was $270 billion in 2019, which it expects to more than double to $590 billion by 2025. As the fastest-growing Medicare Advantage company, Clover Health is in a good position to capitalize on the opportunity.
View more information: https://marketrealist.com/p/why-clov-stock-going-down/